Hematology and Oncology

About Us

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.

Kehinde U.A. Adekola

Associate Professor of Medicine (Hematology and Oncology)

Interested in stem cell/bone marrow transplantation for malignant and non-malignant disorders, and patient outcomes after these transplants. Interested in cancer health disparities specifically in hematologic disorders. Interested in global health with improvement in outcomes for hematologic and oncologic conditions in all regions.

Leo I Gordon

Professor of Medicine (Hematology and Oncology)

The overarching goal of my involvement in translational research is to improve the outcome of patients with lymphoma. With scientists in the US and abroad, we are currently investigating novel signaling pathways in lymphoma, using cell lines and animal model systems. More specifically, our research focuses on the biology of reactive oxygen species signaling pathways in lymphoma. Active investigations include: 1) the biology of the lactone diterpenoids in lymphoma; 2) the development of all trans retinoic acid (ATRA) and curcumin loaded nanodisks as a drug delivery vehicle in mantle cell lympho...

Seema Singhal

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Jayesh Mehta

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Marcus Ernst Peter

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

The lab of Dr. Marcus E. Peter studies various forms of cell death including apoptosis, which is a fundamental process to regulate homeostasis of all tissues and to eliminate unwanted cells specifically in the immune system. Another interest lies in the study of RNA interference and based on toxic RNAs to development a novel form of cancer treatment. The laboratory is located within the Robert H. Lurie Cancer Center at Northwestern University.

Jonathan Moreira

Associate Professor of Medicine (Hematology and Oncology)

Dr. Jonathan Moreira is an Assistant Professor of Medicine in the Department of Medicine, Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine. After receiving dual bachelor degrees at the University of Illinois at Urbana-Champaign, he returned to his native Chicago, where he received a medical degree from Loyola University Chicago’s Stritch School of Medicine. He then went on to complete a residency in Internal Medicine at Mayo Clinic in Rochester, Minnesota. He returned to Chicago to complete a fellowship in Hematology/Oncology at Northwestern University’s...

Timothy Kuzel

Clinical Professor of Medicine (Hematology and Oncology)

Immunotherapy strategies for treatment of melanoma, renal cell cancer, other urologic tumors and Mycosis fungoides

Mary F Mulcahy

Professor of Medicine (Hematology and Oncology), Radiology and Surgery (Organ Transplantation)

Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer

Jeffrey A Sosman

Professor of Medicine (Hematology and Oncology)

I have been an active clinical investigator vested in the immune-based therapy of melanoma. This has led to my role in the clinical development of initially Interleukin-2 and more recently anti-CTLA-4 and anti-PD1/PDL-1. While checkpoint therapy has been a great breakthrough in cancer treatment, additional immune-based strategies are still critically needed. Efforts to identify mechanisms of resistance to checkpoint inhibitors and approaches to overcome de novo and acquired resistance are one of my major interest. In addition I have ongoing efforts in the personalized therapy of melanoma with ...

Lisa E Flaum

Associate Professor of Medicine (Hematology and Oncology)

My clinical practice involves the medical treatment of breast cancer in women and men with a particular interest in young women with breast cancer. My clinical research endeavors involve chemotherapy, endocrine therapy, and novel therapies for the treatment of breast cancer. I am interested in ways to optimize and individualize breast cancer treatment based on patient characteristics as well as tumor specific molecular profiles.

Contact Us

We welcome your questions and comments.

Learn More

Diversity and Inclusion

The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.

Learn More

Housestaff Research Portal

Former PSTP Trainee Luisa Morales Nebreda, MD

Physician-Scientist Training & Resources

We offer a wide range of resources, mentorship opportunities and formal training programs to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.

VISIT THE STARZL ACADEMY SITE

Giving

Support What We Do
Terri Dillon

We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.

Make an online donation

Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.